Qin Liu1, Alexei Saveliev, Eric A Pierce. 1. F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
Abstract
PURPOSE: The severity of disease in patients with retinitis pigmentosa (RP) can vary significantly, even among patients with the same primary mutations. It is hypothesized that modifier genes play important roles in determining the severity of RP, including the retinitis pigmentosa 1 (RP1) form of disease. To investigate the basis of variation in disease expression for RP1 disease, the authors generated congenic mice with a gene-targeted retinitis pigmentosa 1 homolog (Rp1h) allele (Rp1h(tm1Eap)) on several different genetic backgrounds and analyzed their retinal phenotypes. METHODS: The Rp1h(tm1Eap) allele was placed onto the C57BL/6J, DBA1/J, and A/J backgrounds. Retinal function of the resultant congenic mice was evaluated using electroretinographic analyses. Retinal structure and ultrastructure were evaluated using light and electron microscopy. Rp1h protein location was determined with immunofluorescence microscopy. RESULTS: Analysis of the retinal phenotype of incipient congenic (N6) B6.129S-Rp1h(+/tm1Eap), DBA.129S(B6)-Rp1h(+/tm1Eap), and A.129S(B6)-Rp1h(+/tm1Eap) mice at 1 year of age showed retinal degeneration only in the A.129S(B6)-Rp1h(+/tm1Eap) mice. Further analyses revealed that the photoreceptors of the fully congenic A.129S(B6)-Rp1h(+/tm1Eap) mice show evidence of degeneration at 6 months of age and are almost completely lost by 18 months of age. In contrast, the photoreceptor cells in the fully congenic B6.129S-Rp1h(+/tm1Eap) mice remain healthy up to 18 months. CONCLUSIONS: The severity of the retinal degeneration caused by the Rp1h(tm1Eap) allele is notably dependent on genetic background. The development and characterization of the B6.129S-Rp1h(+/tm1Eap) and A.129S(B6)-Rp1h(+/tm1Eap) congenic mouse lines will facilitate identification of sequence alterations in genes that modify the severity of RP1 disease.
PURPOSE: The severity of disease in patients with retinitis pigmentosa (RP) can vary significantly, even among patients with the same primary mutations. It is hypothesized that modifier genes play important roles in determining the severity of RP, including the retinitis pigmentosa 1 (RP1) form of disease. To investigate the basis of variation in disease expression for RP1 disease, the authors generated congenic mice with a gene-targeted retinitis pigmentosa 1 homolog (Rp1h) allele (Rp1h(tm1Eap)) on several different genetic backgrounds and analyzed their retinal phenotypes. METHODS: The Rp1h(tm1Eap) allele was placed onto the C57BL/6J, DBA1/J, and A/J backgrounds. Retinal function of the resultant congenic mice was evaluated using electroretinographic analyses. Retinal structure and ultrastructure were evaluated using light and electron microscopy. Rp1h protein location was determined with immunofluorescence microscopy. RESULTS: Analysis of the retinal phenotype of incipient congenic (N6) B6.129S-Rp1h(+/tm1Eap), DBA.129S(B6)-Rp1h(+/tm1Eap), and A.129S(B6)-Rp1h(+/tm1Eap) mice at 1 year of age showed retinal degeneration only in the A.129S(B6)-Rp1h(+/tm1Eap) mice. Further analyses revealed that the photoreceptors of the fully congenic A.129S(B6)-Rp1h(+/tm1Eap) mice show evidence of degeneration at 6 months of age and are almost completely lost by 18 months of age. In contrast, the photoreceptor cells in the fully congenic B6.129S-Rp1h(+/tm1Eap) mice remain healthy up to 18 months. CONCLUSIONS: The severity of the retinal degeneration caused by the Rp1h(tm1Eap) allele is notably dependent on genetic background. The development and characterization of the B6.129S-Rp1h(+/tm1Eap) and A.129S(B6)-Rp1h(+/tm1Eap) congenic mouse lines will facilitate identification of sequence alterations in genes that modify the severity of RP1 disease.
Authors: A Payne; E Vithana; S Khaliq; A Hameed; J Deller; L Abu-Safieh; S Kermani; B P Leroy; S Q Mehdi; A T Moore; A C Bird; S S Bhattacharya Journal: Invest Ophthalmol Vis Sci Date: 2000-12 Impact factor: 4.799
Authors: E L Berson; J L Grimsby; S M Adams; T L McGee; E Sweklo; E A Pierce; M A Sandberg; T P Dryja Journal: Invest Ophthalmol Vis Sci Date: 2001-09 Impact factor: 4.799
Authors: N Katsanis; S J Ansley; J L Badano; E R Eichers; R A Lewis; B E Hoskins; P J Scambler; W S Davidson; P L Beales; J R Lupski Journal: Science Date: 2001-09-21 Impact factor: 47.728
Authors: S G Jacobson; A V Cideciyan; A Iannaccone; R G Weleber; G A Fishman; A M Maguire; L M Affatigato; J Bennett; E A Pierce; M Danciger; D B Farber; E M Stone Journal: Invest Ophthalmol Vis Sci Date: 2000-06 Impact factor: 4.799
Authors: Qin Liu; Jie Zhou; Stephen P Daiger; Debora B Farber; John R Heckenlively; Julie E Smith; Lori S Sullivan; Jian Zuo; Ann H Milam; Eric A Pierce Journal: Invest Ophthalmol Vis Sci Date: 2002-01 Impact factor: 4.799
Authors: Jungyeon Won; Jeremy R Charette; Vivek M Philip; Timothy M Stearns; Weidong Zhang; Jürgen K Naggert; Mark P Krebs; Patsy M Nishina Journal: Exp Eye Res Date: 2013-11-04 Impact factor: 3.467
Authors: Jennifer E Westfall; Carlton Hoyt; Qin Liu; Yi-Chun Hsiao; Eric A Pierce; Patrick S Page-McCaw; Russell J Ferland Journal: J Neurosci Date: 2010-06-30 Impact factor: 6.167
Authors: Hortensia Sanchez-Calderon; Lourdes Rodriguez-de la Rosa; Marta Milo; Jose G Pichel; Matthew Holley; Isabel Varela-Nieto Journal: PLoS One Date: 2010-01-25 Impact factor: 3.240
Authors: Qin Liu; Rob W J Collin; Frans P M Cremers; Anneke I den Hollander; L Ingeborgh van den Born; Eric A Pierce Journal: PLoS One Date: 2012-08-21 Impact factor: 3.240